Woyach, J. A., Yin, J., Brown, J. R., Dinner, S., Lozanski, G., Little, R. F., … Byrd, J. C. (2023). Results of a phase 3 study of IVO vs IO for previously untreated older patients (pts) with chronic lymphocytic leukemia (CLL) and impact of COVID-19 (Alliance). In JOURNAL OF CLINICAL ONCOLOGY (Vol. 41).

Woyach, Jennifer Ann, Jun Yin, Jennifer R. Brown, Shira Dinner, Gerard Lozanski, Richard F. Little, Cecelia Miller, et al. “Results of a phase 3 study of IVO vs IO for previously untreated older patients (pts) with chronic lymphocytic leukemia (CLL) and impact of COVID-19 (Alliance).” In JOURNAL OF CLINICAL ONCOLOGY, Vol. 41, 2023.

Woyach JA, Yin J, Brown JR, Dinner S, Lozanski G, Little RF, et al. Results of a phase 3 study of IVO vs IO for previously untreated older patients (pts) with chronic lymphocytic leukemia (CLL) and impact of COVID-19 (Alliance). In: JOURNAL OF CLINICAL ONCOLOGY. 2023.

Woyach, Jennifer Ann, et al. “Results of a phase 3 study of IVO vs IO for previously untreated older patients (pts) with chronic lymphocytic leukemia (CLL) and impact of COVID-19 (Alliance).” JOURNAL OF CLINICAL ONCOLOGY, vol. 41, no. 16, 2023.

Woyach JA, Yin J, Brown JR, Dinner S, Lozanski G, Little RF, Miller C, Damarla VK, Coutre SE, Ding W, Hill BT, Burbano GP, Ruppert AS, Wall AKM, Feldman D, Dib EG, Erba HP, Litzow MR, Stone RM, Byrd JC. Results of a phase 3 study of IVO vs IO for previously untreated older patients (pts) with chronic lymphocytic leukemia (CLL) and impact of COVID-19 (Alliance). JOURNAL OF CLINICAL ONCOLOGY. 2023.